标题
Dengue Fever: Causes, Complications, and Vaccine Strategies
作者
关键词
-
出版物
Journal of Immunology Research
Volume 2016, Issue -, Pages 1-14
出版商
Hindawi Limited
发表日期
2016-07-21
DOI
10.1155/2016/6803098
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The global burden of dengue: an analysis from the Global Burden of Disease Study 2013
- (2016) Jeffrey D Stanaway et al. LANCET INFECTIOUS DISEASES
- The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
- (2016) Beth D. Kirkpatrick et al. Science Translational Medicine
- Protective and immunological behavior of chimeric yellow fever dengue vaccine
- (2016) Scott B. Halstead et al. VACCINE
- A Phase II, Randomized, Safety and Immunogenicity Trial of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Children and Adults Living in Puerto Rico
- (2015) Kristen Bauer et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Animal models for studying dengue pathogenesis and therapy
- (2015) Kitti Wing Ki Chan et al. ANTIVIRAL RESEARCH
- Development of TV003/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD™ vaccine?
- (2015) Stephen S. Whitehead Expert Review of Vaccines
- Dengue vaccines: Challenges, development, current status and prospects
- (2015) L Dar et al. Indian Journal of Medical Microbiology
- Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice
- (2015) Satoru Watanabe et al. JOURNAL OF VIROLOGY
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dengue vaccines at a crossroad
- (2015) A. Wilder-Smith et al. SCIENCE
- Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers
- (2015) G. Fibriansah et al. SCIENCE
- Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination
- (2015) P. Robert Beatty et al. Science Translational Medicine
- Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity
- (2015) Naphak Modhiran et al. Science Translational Medicine
- Preclinical and clinical development of a dengue recombinant subunit vaccine
- (2015) Susan B. Manoff et al. VACCINE
- Preclinical development of a dengue tetravalent recombinant subunit vaccine: Immunogenicity and protective efficacy in nonhuman primates
- (2015) Dhanasekaran Govindarajan et al. VACCINE
- Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine
- (2015) Alexander Roberto Precioso et al. VACCINE
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
- (2014) Jorge E Osorio et al. LANCET INFECTIOUS DISEASES
- Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
- (2014) William B. Messer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Coupling of replication and assembly in flaviviruses
- (2014) Swapna Apte-Sengupta et al. Current Opinion in Virology
- Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors
- (2014) Carolina De La Guardia et al. Biomed Research International
- T-Cell Immunity to Infection with Dengue Virus in Humans
- (2014) Daniela Weiskopf et al. Frontiers in Immunology
- Mouse Models to Study Dengue Virus Immunology and Pathogenesis
- (2014) Raphaël M. Zellweger et al. Frontiers in Immunology
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds
- (2013) Luis Á. Villar et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
- (2013) D. Weiskopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identifying protective dengue vaccines: Guide to mastering an empirical process
- (2013) Scott B. Halstead VACCINE
- Safety and immunogenicity of three tetravalent dengue vaccine formulations in healthy adults in the USA
- (2013) Gustavo H. Dayan et al. VACCINE
- A Phase II, Randomized, Safety and Immunogenicity Study of a Re-Derived, Live-Attenuated Dengue Virus Vaccine in Healthy Adults
- (2012) Stephen J. Thomas et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Aedes albopictus and the reemergence of Dengue
- (2012) Giovanni Rezza BMC PUBLIC HEALTH
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
- (2012) R. de Alwis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A dengue DNA vaccine formulated with Vaxfectin®is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits
- (2012) Kanakatte Raviprakash et al. Human Vaccines & Immunotherapeutics
- Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus
- (2012) Oliver J. Brady et al. PLoS Neglected Tropical Diseases
- Efficacy of a Tetravalent Chimeric Dengue Vaccine (DENVax) in Cynomolgus Macaques
- (2011) Jorge E. Osorio et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants
- (2011) Veerachai Watanaveeradej et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Immune Response to Dengue Virus and Prospects for a Vaccine
- (2011) Brian R. Murphy et al. Annual Review of Immunology
- Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries
- (2011) Judit Barniol et al. BMC INFECTIOUS DISEASES
- Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: Randomized controlled phase I trial in the Philippines
- (2011) Rosario Z. Capeding et al. VACCINE
- Development of dengue DNA vaccines
- (2011) Janine R. Danko et al. VACCINE
- Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine
- (2011) Kevin R. Porter et al. VACCINE
- Dengue — Quo tu et quo vadis?
- (2011) Rubing Chen et al. Viruses-Basel
- Evaluation of the Traditional and Revised WHO Classifications of Dengue Disease Severity
- (2011) Federico Narvaez et al. PLoS Neglected Tropical Diseases
- In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
- (2011) Ruklanthi de Alwis et al. PLoS Neglected Tropical Diseases
- Domain III of the envelope protein as a dengue vaccine target
- (2010) Maria G Guzman et al. Expert Review of Vaccines
- Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naïve adults
- (2010) Wellington Sun et al. Human vaccines & immunotherapeutics
- A Novel Tetravalent Dengue Vaccine Is Well Tolerated and Immunogenic against All 4 Serotypes inFlavivirus‐Naive Adults
- (2010) Dennis Morrison et al. JOURNAL OF INFECTIOUS DISEASES
- Different Innate Signatures Induced in Human Monocyte-derived Dendritic Cells by Wild-Type Dengue 3 Virus, Attenuated but Reactogenic Dengue 3 Vaccine Virus, or Attenuated Nonreactogenic Dengue 1-4 Vaccine Virus Strains
- (2010) C. Balas et al. JOURNAL OF INFECTIOUS DISEASES
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys
- (2010) David E. Clements et al. VACCINE
- Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial
- (2010) Charmagne G. Beckett et al. VACCINE
- Protection against dengue virus by non-replicating and live attenuated vaccines used together in a prime boost vaccination strategy
- (2009) Monika Simmons et al. VIROLOGY
- Closing the door on flaviviruses: Entry as a target for antiviral drug design
- (2008) Rushika Perera et al. ANTIVIRAL RESEARCH
- Structural proteomics of dengue virus
- (2008) Rushika Perera et al. CURRENT OPINION IN MICROBIOLOGY
- A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus
- (2008) K. Raviprakash et al. JOURNAL OF VIROLOGY
- Construction and Characterization of a Single-Cycle Chimeric Flavivirus Vaccine Candidate That Protects Mice against Lethal Challenge with Dengue Virus Type 2
- (2008) R. Suzuki et al. JOURNAL OF VIROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation